Journals in Cardiology and cardiovascular medicine

American Heart Journal

ISSN: 0002-8703
5 Year impact factor: 3.6
Impact factor: 3.7

The American Heart Journal will consider for publication suitable articles on topics pertaining to the broad discipline of cardiovascular disease. Our goal is to provide the reader primary investigation, scholarly review, and opinion concerning the practice of cardiovascular medicine. We especially encourage submission of 3 types of reports that are not frequently seen in cardiovascular journals: negative clinical studies, reports on study designs, and studies involving the organization of medical care. The Journal does not accept individual case reports or original articles involving bench laboratory or animal research.

Subscriptions

American Journal of Preventive Cardiology

ISSN: 2666-6677
5 Year impact factor: 4.5
Impact factor: 4.3

Published quarterly, The American Journal of Preventive Cardiology is the official journal the American Society for Preventive Cardiology . It publishes articles in the areas of prevention research, teaching, practice and policy. Original research and reviews are published on epidemiology and clinical studies on risk factors, behavioral and pharmacologic interventions aimed at the primary and secondary prevention of cardiovascular diseases and related conditions, as well as the promotion of individual and community cardiovascular health.The journal publishes both original research and review papers that address the key aspects of preventive cardiology, including the primary and secondary prevention of cardiovascular disease and related conditions including both behavioral (e.g., smoking, obesity, diet, and physical activity) and clinical (e.g., dyslipidemia, hypertension, and diabetes) aspects. Papers also address educational and other initiatives and methods aimed at improving the ability of cardiologists and healthcare professionals to provide effective clinical prevention and public health services. The journal also publishes guidelines and official policy statements from the Society, review articles, media reviews, and editorials. Finally, the journal periodically publishes special theme issues devoted to areas of current interest to the cardiac prevention community. Also included are editorials, readers' comments, and abstracts from the annual ASPC scientific sessions.

Subscriptions

American Journal of Preventive Medicine

ISSN: 0749-3797
5 Year impact factor: 4.9
Impact factor: 4.3

A Journal of the American College of Preventive Medicine and the Association for Prevention Teaching and ResearchThe American Journal of Preventive Medicine is the official journal of the American College of Preventive Medicine and the Association for Prevention Teaching and Research. It publishes articles in the areas of prevention research, teaching, practice and policy. Original research is published on interventions aimed at the prevention of chronic and acute disease and the promotion of individual and community health.Of particular emphasis are papers that address the primary and secondary prevention of important clinical, behavioral and public health issues such as injury and violence, infectious disease, women's health, smoking, sedentary behaviors and physical activity, nutrition, diabetes, obesity, and substance use disorders. Papers also address educational initiatives aimed at improving the ability of health professionals to provide effective clinical prevention and public health services. Papers on health services research pertinent to prevention and public health are also published. The journal also publishes official policy statements from the two co-sponsoring organizations, review articles, media reviews, and editorials. Finally, the journal periodically publishes supplements and special theme issues devoted to areas of current interest to the prevention community.For information on the American College of Preventive Medicine (ACPM) and the Association for Prevention Teaching and Research (APTR), visit their web sites at the following URLs: http://www.acpm.org/ and http://www.aptrweb.org

Subscriptions

Annals of Epidemiology

ISSN: 1047-2797
5 Year impact factor: 4
Impact factor: 3.3

Sponsored by the American College of EpidemiologyAnnals of Epidemiology is devoted to epidemiologic research and methodological development. The journal emphasizes the application of epidemiologic methods to issues that affect the distribution and determinants of human illness in diverse contexts, and their impact on public health. Its primary focus is on chronic and acute conditions of diverse etiologies and of major importance to clinical medicine, public health, and health care delivery.Annals encourages the use of epidemiology in a multidisciplinary approach to understanding disease etiology. Annals accepts submissions in the following categories: Original research, Review articles, Editorials, Commentaries, Brief Communications, Letters to the Editor, and Protocols/Methods papers.The journal publishes topics including:Infectious and chronic diseasesEnvironmental healthPopulation based methods to describe health and disease and their determinantsNovel applications of epidemiologic methodsNovel data sources including registries, metadata, paradataAssessments of local and state public health data and programs using epidemiologic methodsUse of public health data and metrics to describe and assess equity in public health programsProtocols and methods, especially with novel study designs or analytic approachesFor more information concerning the American College of Epidemiology (ACE), please visit their home page at acepidemiology.org .

Subscriptions

Annals of Thoracic Surgery Short Reports

ISSN: 2772-9931

Annals of Thoracic Surgery Short Reports ("Annals Short Reports") welcomes a wide range of short-form original research related to clinical advances, current surgical methods, controversial topics and techniques, case and image reports, for adult acquired and congenital cardiovascular disease, thoracic surgery, cardiothoracic transplantation, mechanical circulatory support, perioperative medicine, as well as education and training, with a special emphasis on digital media and supplemental content, designed for easy and open sharing of data, results, and content across our social media and other channels in coordination with our publisher, Elsevier.Annals Short Reports aims to attract sound science-emerging data, pilot studies, clinical trial protocol and design studies, new technologies, techniques, education curriculums, and methodology and case reports. Annals Short Reports is committed to providing a new venue for cardiothoracic surgeons to relate experiences in a modern approach which will help improve patient care.

Subscriptions

Atherosclerosis

ISSN: 0021-9150
5 Year impact factor: 5.3
Impact factor: 4.9

Cardiovascular disease (CVD) causes one third of all deaths worldwide and is a major threat to global health. Atherosclerosis aims to provide a comprehensive platform for researchers, clinicians and healthcare professionals to share the latest findings and advances in the field of atherosclerosis. Atherosclerosis covers a wide range of topics, including:Pathophysiology and Mechanisms: We explore the intricate cellular and molecular processes involved in atherogenesis, from the initial formation of fatty streaks to the development of complex plaques. We also welcome studies on cardiac biology and disease.Risk Factors: We consider manuscripts that examine both traditional and emerging risk factors for atherosclerosis, such as dyslipidaemia, hypertension, diabetes mellitus, thrombosis and genetic predisposition.Prevention of CVD: Since prevention will become a major focus in the future (see e.g. the European Cardiovascular Health Plan), an important focus will be on preventive strategies, including lifestyle modifications and pharmacological interventions.Diagnostics Techniques: We features articles on cutting-edge diagnostic techniques, ranging from invasive procedures such as selective coronary arteriography to non-invasive techniques such as blood biomarkers.Treatment Approaches: Atherosclerosis covers the latest developments in the treatment of atherosclerosis, including lipid-lowering therapies, anti-inflammatory treatments and novel targeted approaches aimed at modifying disease progression and improving clinical outcomes.Translational Research: We bridges the gap between basic science and clinical practice by highlighting translational studies that bring laboratory findings closer to practical applications in patient care.By fostering collaboration and knowledge exchange between researchers and clinicians, Atherosclerosis aims to accelerate progress in the understanding, prevention and treatment of atherosclerosis, ultimately improving the lives of the millions of people affected by this pervasive disease.

Subscriptions

Atherosclerosis: X

ISSN: 2590-1354

Atherosclerosis: X is the open access mirror journal of https://www.journals.elsevier.com/atherosclerosis Atherosclerosis.Atherosclerosis: X offers authors with high-quality research who want to publish in a gold open access journal the opportunity to make their work immediately, permanently, and freely accessible.Atherosclerosis: X authors will pay an article publishing charge (APC), have a choice of license options, and retain copyright. Please check the APC on https://www.elsevier.com/journals/atherosclerosis-x/2590-1354/open-access-journalthe journal homepage. As an introductory offer for this journal Elsevier will pay the APC and you can publish free of charge. As this title is newly launched, it does not have a CiteScore or Journal Impact Factor yet, however we will apply for inclusion in all the relevant indexing databases as soon as possible. The journal is indexed in Scopus.Atherosclerosis and Atherosclerosis: X have the same aims and scope. A unified editorial team manages rigorous peer-review for both titles using the same submission system. The author's choice of journal is blinded to referees, ensuring the editorial process is identical.For more information please refer to our https://www.elsevier.com/about/open-science/open-access/faqs-open-access-partner-journalsFAQs for authorsAtherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The http://www.journals.elsevier.com/atherosclerosis/editorial-boardEditors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors.

Subscriptions

Biochimica et Biophysica Acta: Bioenergetics

ISSN: 0005-2728
5 Year impact factor: 3.6
Impact factor: 3.4

BBA Bioenergetics covers the area of biological membranes involved in energy transfer and conversion. In particular, it focuses on elucidating molecular mechanisms and structure-function relationships of bioenergetic components of photosynthesis, mitochondrial and bacterial respiration, oxidative phosphorylation, and motility and transport, as well as their structural aspects. The journal spans applications of advanced biochemical and biophysical approaches, including spectroscopy, structural biology, and molecular modeling in these systems. Additionally, it addresses bioenergetic aspects of mitochondrial biology, including biomedical aspects of energy metabolism, also related to mitochondrial disorders and neurodegenerative diseases.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center.

Subscriptions

Biochimica et Biophysica Acta: Molecular Basis of Disease

ISSN: 0925-4439
5 Year impact factor: 5.5
Impact factor: 4.2

BBA Molecular Basis of Disease addresses the biochemistry and molecular genetics of disease processes and models of human disease.Manuscripts should emphasize the underlying molecular mechanisms of human disease pathways and provide significant advances to the understanding and/or treatment of these disorders.Studies in model organisms or systems are strongly recommended in order to validate mechanistic insights. Topics of interest include, but are not limited toAgingCancerCardiovascular diseasesCell death–related diseasesGenetic diseasesGenetic and epigenetic regulation in diseasesImmunological diseasesInflammatory diseasesMetabolic diseasesMitochondrial diseasesMuscular diseasesNeurological diseasesThe non-preferred topics for BBADIS includeNon-coding RNAsResearch on non-coding RNAs (microRNAs, lncRNAs, circRNAs, etc.) will be considered only if it provides significantly novel insights into disease mechanisms.Single Cell Line StudiesStudies involving single cell lines will be considered only if they present significantly novel findings.Computational (in Silico) StudiesPurely computational works (e.g., Mendelian randomization, molecular docking, molecular dynamics) will generally be declined unless they provide novel insights into disease mechanisms.Disease BiomarkersResearch on disease biomarkers will be considered only if it relates to the explanation of disease mechanisms.Descriptive or Correlative StudiesDescriptive or correlative studies (e.g., up/down regulation of gene products, -omics studies without follow-up experiments) will be declined unless they provide mechanistic insights.Natural Products and Traditional MedicineWork on natural products, extracts, and traditional medicine will be considered only if single biochemical components are characterized and tested.Clinical Studies and Case ReportsClinical studies or case reports without mechanistic insights are outside the scope of the journal.Hypothesis ArticlesSubmissions based solely on hypotheses will not be considered.Comparative Genomics StudiesComparative genomics studies (e.g., GWAS) will only be considered if they provide specific insights into the structural and/or functional properties of individual genes.Incremental WorkResearch that offers incremental advancements without significant novelty or impact will generally be declined.

Subscriptions

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids

ISSN: 1388-1981
5 Year impact factor: 4.3
Impact factor: 3.9

BBA Molecular and Cell Biology of Lipids publishes papers on original research dealing with novel aspects of lipid biology including the biosynthesis, degradation, and transport of lipids, the role of lipids and the lipidome in cells and whole organisms, and the regulation of lipid metabolism and function in normative health and disease states.Manuscripts should significantly advance the understanding of the molecular mechanisms underlying biological processes in which lipids are involved using biochemical, biophysical, cell and molecular biological, genetic, or physiological approaches. Papers detailing novel methodology should also include biochemical, molecular, or functional insight in the area of lipids. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Subscriptions

Life Sciences

Physical Sciences & Engineering

Social Sciences & Humanities

Health

Journals in Cardiology and cardiovascular medicine

American Heart Journal

American Journal of Preventive Cardiology

American Journal of Preventive Medicine

Annals of Epidemiology

Annals of Thoracic Surgery Short Reports

Atherosclerosis

Atherosclerosis: X

Biochimica et Biophysica Acta: Bioenergetics

Biochimica et Biophysica Acta: Molecular Basis of Disease

Biochimica et Biophysica Acta: Molecular and Cell Biology of Lipids